Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.

ABSTRACT:

SUBMITTER: Hampel PJ 

PROVIDER: S-EPMC7925672 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature